The DEA has begun a key hearing on reclassifying cannabis from Schedule I to Schedule III, following a recommendation from health authorities. While not legalization, the...
On August 29th, 2023, the U.S. HHS recommended to the DEA that cannabis be reclassified from a Schedule I drug to a Schedule III drug. Rescheduling...